Skip to content
Sign in
Angel networkBacked 1 network startup

Delaware Crossing Investment Group

US angel network investing at pre-seed and seed; part of Vytala Health's US$0.8M pre-seed.

United States
Ticket
—Not published
Assets under management
—
Founded
—
Stages
Pre-seedto Seed
Network startups backed
1
Co-investors
4most often with JumpStart NJ Angel Network

How they invest

Angel investments at pre-seed and seed; no thesis in the record. Network deal: Vytala Health (medical nutrition for malabsorption).

Stage and ticket

Pre-seed and Seed.

Geography

United States (Delaware Valley region implied by name; not confirmed in record).

What makes them say yes

  • Inferred: regional founders
  • Inferred: health products
  • Pre-seed/seed

Red flags

  • Unknown
  • Later-stage

Sectors

Not published

Stages

  • Pre-seed
  • Seed

Geographies

Not published

How to approach

Ask Vytala Health (co-investors include Robin Hood Ventures and JumpStart NJ) for an intro.

Portfolio

1 network startup · no other company

One network deal (Vytala Health, Sep 2024).

Gaps in the portfolio

  • Thesis undocumented

Network startups

  • Vytala HealthSWC 2026 Finalist

    United States · Agri & FoodTech

    Plant-based medical food Seracal using a structured lipid matrix to improve fat and nutrient absorption in malabsorption patients.

    • pre-seed (initial closing)Source$805K ·

Network startups that fit

3 analysed

Telematics-driven insurtech giving small school-transport operators big-fleet safety tools and insurance.

School shuttle service operating in Greater Philadelphia: regional US operating company at pre-seed.

35%confidence

Evidence from the records

  • “School transportation / insurtech”
  • “Greater Philadelphia”
Intro path
Vytala Health (DCIG portfolio)
First step
Ask Vytala Health for an intro.

Tufts spin-off with an IRB-approved ingestible capsule that samples small-intestine microbiome and contents non-invasively.

Ingestible small-intestine sampling capsule: gut health adjacency to Vytala's malabsorption focus.

25%confidence

Evidence from the records

  • “Ingestible small intestine sampling capsule”
  • “Pre-seed”
Intro path
Vytala Health (gut-health peer)
First step
Explore a joint gut-health narrative.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Co-investors

Most often with JumpStart NJ Angel Network, Robin Hood Ventures, and The MBA Fund

Sources

  1. 1biospace.com/press-releases/vytala-inc-debuts-with-initial-close-of-pre-

Profile compiled from public sources. Unknown fields are left empty rather than estimated.